Toll Free: 1-888-928-9744

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016

Published: Jun 1, 2016 | Pages: 50 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2016" provides an overview of Thoracic Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thoracic Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Thoracic Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 4 2 Introduction 5 2.1 Thoracic Aortic Stent Grafts Overview 5 3 Products under Development 6 3.1 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 6 3.2 Thoracic Aortic Stent Grafts - Pipeline Products by Territory 7 3.3 Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path 8 3.4 Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 9 3.5 Thoracic Aortic Stent Grafts - Ongoing Clinical Trials 10 4 Thoracic Aortic Stent Grafts - Pipeline Products under Development by Companies 11 4.1 Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 11 4.2 Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 12 5 Thoracic Aortic Stent Grafts Companies and Product Overview 13 5.1 Cook Medical Incorporated Company Overview 13 5.1.1 Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 13 5.2 Evasc Medical Systems Corp. Company Overview 17 5.2.1 Evasc Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 17 5.3 Medtronic plc Company Overview 19 5.3.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19 5.4 MicroPort Scientific Corporation Company Overview 25 5.4.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 25 5.5 St. Jude Medical, Inc. Company Overview 30 5.5.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30 5.6 TriVascular, Inc. Company Overview 32 5.6.1 TriVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 5.7 W. L. Gore & Associates, Inc. Company Overview 34 5.7.1 W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34 6 Thoracic Aortic Stent Grafts- Recent Developments 38 6.1 Apr 28, 2016: Merit Medical Reports Sales Up 6.6% for the Quarter Ended March 31, 2016 38 6.2 Feb 22, 2016: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2015 38 6.3 Jan 26, 2016: First U.S. patient treated following FDA approval of Cook Medical's Zenith Alpha Thoracic Endovascular Graft 40 6.4 Nov 06, 2015: Merit Medical Names New Chief Financial Officer 40 6.5 Nov 02, 2015: Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015 41 6.6 Oct 22, 2015: Merit Medical Announces Results for the Quarter Ended September 30, 2015 42 6.7 Sep 17, 2015: Cook Medical receives FDA approval for the Zenith Alpha Thoracic Endovascular Graft 44 6.8 Jul 23, 2015: Merit Medical Reports Record Revenues for the Quarter and Six Months Ended June 30, 2015 44 7 Appendix 47 7.1 Methodology 47 7.2 About GlobalData 49 7.3 Contact Us 50 7.4 Disclaimer 50
List of Tables
Table 1: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 6 Table 2: Thoracic Aortic Stent Grafts - Pipeline Products by Territory 7 Table 3: Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path 8 Table 4: Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 9 Table 5: Thoracic Aortic Stent Grafts - Ongoing Clinical Trials 10 Table 6: Thoracic Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 11 Table 7: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 12 Table 8: Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 13 Table 9: Zenith TX2 LP TAA Endovascular Graft - Product Status 14 Table 10: Zenith TX2 LP TAA Endovascular Graft - Product Description 14 Table 11: Cook Medical Incorporated - Ongoing Clinical Trials Overview 15 Table 12: Zenith TX2 LP TAA Endovascular Graft - Zenith TX2 Low Profile Endovascular Graft for Blunt Thoracic Aortic Injury (TRANSFIX) 16 Table 13: Zenith TX2 LP TAA Endovascular Graft - Zenith TX2 Low Profile TAA Endovascular Graft Clinical Study 16 Table 14: Zenith TX2 LP TAA Endovascular Graft - Zenith TX2 Low Profile TAA Endovascular Graft Clinical Study 16 Table 15: Evasc Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 17 Table 16: TAS System - Product Status 18 Table 17: TAS System - Product Description 18 Table 18: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19 Table 19: Valiant EVO - Product Status 20 Table 20: Valiant EVO - Product Description 20 Table 21: Valiant Mona LSA System - Product Status 21 Table 22: Valiant Mona LSA System - Product Description 21 Table 23: Medtronic plc - Ongoing Clinical Trials Overview 22 Table 24: Valiant Mona LSA System - Valiant Mona LSA Stent Graft System Early Feasibility Study 23 Table 25: Valiant Mona LSA System - Valiant Mona LSA Thoracic Stent Graft System Feasibility Study 23 Table 26: Valiant EVO - Valiant Evo International Clinical Trial 24 Table 27: Valiant EVO - Valiant Evo US Clinical Trial 24 Table 28: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 25 Table 29: Castor Branched Stent Graft System - Product Status 26 Table 30: Castor Branched Stent Graft System - Product Description 26 Table 31: Hercules - LP - Product Status 27 Table 32: Hercules - LP - Product Description 27 Table 33: MicroPort Scientific Corporation - Ongoing Clinical Trials Overview 28 Table 34: Castor Branched Stent Graft System - A Multi-center Trial of Castor Single-Branched Stent Graft System for Endovascular Repair of Aortic Dissection 29 Table 35: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30 Table 36: Amplatzer TAA Vascular Graft - Product Status 31 Table 37: Amplatzer TAA Vascular Graft - Product Description 31 Table 38: TriVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32 Table 39: Ovation Thoracic Stent Graft System - Product Status 33 Table 40: Ovation Thoracic Stent Graft System - Product Description 33 Table 41: W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34 Table 42: GORE TAG Thoracic Branch Endoprosthesis - Product Status 35 Table 43: GORE TAG Thoracic Branch Endoprosthesis - Product Description 35 Table 44: W. L. Gore & Associates, Inc. - Ongoing Clinical Trials Overview 36 Table 45: GORE TAG Thoracic Branch Endoprosthesis - GORE TAG Thoracic Branch Endoprosthesis Early Feasibility Study 37 Table 46: Glossary 48


List of Figures
Figure 1: Thoracic Aortic Stent Grafts - Pipeline Products by Stage of Development 6 Figure 2: Thoracic Aortic Stent Grafts - Pipeline Products by Territory 7 Figure 3: Thoracic Aortic Stent Grafts - Pipeline Products by Regulatory Path 8 Figure 4: Thoracic Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 9 Figure 5: Thoracic Aortic Stent Grafts - Ongoing Clinical Trials 10

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify